Long-term effectiveness and safety of a three-piece acrylic hydrophobic intraocular lens modified with hydroxyethyl-methacrylate: an open-label, 3-year follow-up study
Authors:
Open Access
- 1 October 2018
- journal article
- research article
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 12, 2031-2037
Abstract
Background: Clareon® is a new hydrophobic acrylic optic biomaterial designed for enhanced clarity and greater resistance to glistening. The present study evaluated the effectiveness and safety of a three-piece hydrophobic, monofocal intraocular lens (IOL) Model MA60NM, made of this new optic material. Methods: In this prospective, multicenter, open-label study, eligible patients aged ≥60 years, underwent a unilateral implantation with IOL Model MA60NM following phacoemulsification. Patients were followed-up for up to 3 years after implantation. Visual outcome and serious adverse events (SAEs, cumulative and persistent) were compared to ISO grid rates (BS EN ISO 11979-7:2006). The primary effectiveness variable was Best Spectacle-Corrected Visual Acuity (BSCVA) at 1-year postoperative follow-up. In addition, posterior capsular opacification (PCO) was assessed qualitatively and graded by slit lamp exam on a 5-point scale at all visits. Results: Overall, 179 and 138 patients completed the 1-year and 3-year postoperative follow-up, respectively. The BSCVA outcomes were better with IOL Model MA60NM than the ISO grid rates with 95.5% of patients at 1 year and 94.2% of patients at 3 years having achieved a BSCVA of 20/40 or better vs 92.5% in ISO grid. The incidence of cumulative or persistent SAEs was lower after Model MA60NM implantation than the ISO grid reference. The incidence of clinically significant PCO was 1.1% at the 1-year and 2.2% at the 3-year visit. Posterior capsulotomy rate was 1.1% at 1 year and 1.4% at 3 years. Conclusion: The three-piece hydrophobic, monofocal IOL Model MA60NM was effective for the visual correction of aphakia and successfully met all the safety parameters as defined by the ISO criteria. PCO and posterior capsulotomy rates were low over the 3-year follow-up period. This study provides evidence and supports the long-term safety and effectiveness of the new optic biomaterial Clareon®.Keywords
This publication has 33 references indexed in Scilit:
- Posterior Capsule Opacification 9 Years after Phacoemulsification with a Hydrophobic and a Hydrophilic Intraocular LensEuropean Journal of Ophthalmology, 2016
- Economic considerations related to choice of intraocular lens (IOL) and posterior capsule opacification frequency – a comparison of three different IOLsActa Ophthalmologica, 2012
- Comparison of posterior capsule opacification development with 3 intraocular lens typesJournal of Cataract & Refractive Surgery, 2009
- Posterior Capsular OpacificationArchives of Ophthalmology (1950), 2009
- Efficacy of Different Intraocular Lens Materials and Optic Edge Designs in Preventing Posterior Capsular Opacification: A Meta-AnalysisAmerican Journal of Ophthalmology, 2007
- Comparison of the biomechanical behavior of foldable intraocular lensesJournal of Cataract & Refractive Surgery, 2004
- Neodymium:YAG laser posterior capsulotomy after implantation of AcrySof intraocular lensesJournal of Cataract & Refractive Surgery, 2004
- Evaluation of neodymium:yttrium-aluminum-garnet capsulotomies in eyes implanted with AcrySof intraocular lenses 1 1The authors have no financial or proprietary interest in any products mentioned in this paper.Ophthalmology, 2002
- Effect of round-edged acrylic intraocular lenses on preventing posterior capsule opacificationJournal of Cataract & Refractive Surgery, 2001
- Eradication of posterior capsule opacificationOphthalmology, 2001